Tag: Vineet Singhal
Takeda expands India portfolio of rare disease therapies
The company has launched Enzyme Replacement Therapy bouquet for Lysosomal Storage Disorders (LSD), Idursulfase for Hunter Syndrome, Velaglucerase Alpha for Gaucher Disease and Agalsidase Alfa for Fabry Disease..........................
Shire launches DosEdge in India
The new hemophilia factor-dosage calculation mobile app for healthcare professionals, available free on Apple App Store and Google Play Store, ensures dosage accuracy for patients with hemophilia...………...
“We plan to bring first in line treatment for acute lymphoblastic...
Mentioned Mr Vineet Singhal, Country Head, Shire India who shared his detailed views on his company’s activities as well as the social and policy aspects related to rare diseases. Read the full interview........
BioVoice eMag October 2017 Issue-5 Volume-2
BioVoice eMag October 2017 Issue-5 Volume-2:
The ‘October 2017’ edition of BioVoice magazine in its detailed ‘Cover Story’ focuses on the serious issue of pink bollworm...